Amgen News

The Nasdaq 100 index rose slightly in an abbreviated trading session Thursday as Wall Street weighed record-high crude oil prices and reports showing a drop in the service sector, but an unchanged unemployment ...

Amgen Inc. 's experimental osteoporosis drug may become the top remedy for the bone- thinning disorder, gaining about half of an $8 billion annual market and reviving shares.

Later this month, Delta Air Lines customers will be able to avoid long security lines at Los Angeles International Airport by enrolling in a national program that provides priority lanes in passenger terminals.

Amgen Inc. 's experimental cancer drug motesanib delayed or reversed growth of thyroid tumors in a small study of patients with advanced malignancies.

The findings indicate that keeping parathyroid hormone, calcium, and phosphorous levels in control is critically important for dialysis patients with chronic kidney disease .

DxS Launches Cancer Mutation Kit For K-RAS In Australia - New Diagnostic Assists Clinicians In Selecting Appropriate Cancer Therapy For Patients Main Category: Cancer / Oncology Also Included In: Medical ...

Amgen today announced updated results from the "STEPP" trial, the first prospective - PRINCETON, N.J.-- --Bristol-Myers Squibb Company announced today that it has completed its previously announced $190 million ...

Akesis Pharmaceuticals, Inc. , an emerging diabetes drug-development company, today announced it has named Carl LeBel, Ph.D., as president and chief operating officer.

GastroIntestinal / Gastroenterology Amgen announced updated results from the "STEPP" trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities ...

Fluxion Biosciences announced today an exclusive distribution agreement with Basel-based Bucher Biotec AG.

The life sciences industry ponied up a record dollar amount to lobby Congress last year, according to a new Center for Public Integrity report.

An advisory panel to the Food and Drug Administration has recommended the agency expand the approved use of Amgen Inc.'s Enbrel, The Wall Street Journal reported on its Web site Wednesday.

New Brunswick-based Johnson & Johnson urged a U.S. advisory panel to recommend approval of its experimental drug, ustekinumab, for the 7.5 million Americans with the skin disorder psoriasis.

Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee Meeting THOUSAND OAKS, Calif.

U.S. health officials should approve wider use of Amgen Inc's drug Enbrel to treat psoriasis in children, a Food and Drug Administration advisory panel said on Wednesday.

Birmingham-based BioCryst Pharmaceuticals Inc . said today that Dr. William P. Sheridan has been appointed the company's chief medical officer.

Federal regulators said Monday an Amgen drug used to treat a severe skin disorder was associated with sometimes lethal infections when used in children.

Biotech drugmaker Amgen Inc. is among the companies that could see profits trimmed by a Congressional spending bill aimed at streamlining the Medicare program.

Even as he's caught square in the sights of this terrible market, noted money manager Richard Pzena exudes confidence -- despite his big bets on Fannie Mae , Freddie Mac , and Citigroup thus far looking nothing ...

Fitch expects to rate Chase Issuance Trust CHASEseries Class A, Notes as follows: - THOUSAND OAKS, Calif.-- --Amgen Senior Vice President of North American Commercial Operations James Daly will present at the ...